English | Español
Patient Daily | Mar 18, 2026

FARE to participate in congressional briefing on food allergy research and public health
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
Patient Daily | Mar 18, 2026

Experimental hookworm vaccine shows promising protection in phase 2 human trial
Patient Daily | Mar 18, 2026

American Tort Reform Association releases report on scientific claims in mass tort litigation
Patient Daily | Mar 17, 2026

FDA move to single pivotal study raises standards for drug applications
Patient Daily | Mar 17, 2026

Novo Holdings’ assets fell 34% in 2025 as Novo Nordisk struggled
Patient Daily | Mar 17, 2026

J&J and AbbVie CEOs receive pay increases exceeding $30 million in 2025
Patient Daily | Mar 17, 2026

BridgeBio reports positive Phase 3 results for limb-girdle muscular dystrophy drug

Trending
+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug